Literature DB >> 498890

Internal radiation therapy of hepatic cancer.

E D Grady.   

Abstract

Established cancer in the liver can, in selected patients who have a good arterial circulation in these tumors, be effectively treated by intrahepatic artery radioactive yttrium-90 resin microspheres. Even in unselected patients treated in the last five years by the author, 17 of 25 patients treated have had good objective regression of cancers, improvement of symptoms and prolongation of life. Treatment is relatively simple and associated with few side effects. For adjuvant therapy of colon cancer having positive nodes (Dukes C), internal radiation therapy of the liver is best done with Phosphorus-32 Colloid passed through the circulation of the gut to be effectively and homogeneously trapped by the Kupffer cells of the liver. Four such patients have been subjected to a pilot study--three of the four are doing well without significant side effects and no evidence of liver cancer after two years. When the fourth died of brain metastases, he too had less liver cancer than would be expected.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 498890     DOI: 10.1007/bf02586901

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  15 in total

1.  Radioembolization of yttrium-90 microspheres for hepatic malignancy.

Authors:  Ravi Murthy; Paresh Kamat; Rodolfo Nuñez; Riad Salem
Journal:  Semin Intervent Radiol       Date:  2008-03       Impact factor: 1.513

2.  Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours.

Authors:  S Ho; W Y Lau; T W Leung; M Chan; Y K Ngar; P J Johnson; A K Li
Journal:  Eur J Nucl Med       Date:  1996-08

Review 3.  Principles of Radioembolization.

Authors:  Gajan Sivananthan; Nora E Tabori
Journal:  Semin Intervent Radiol       Date:  2021-10-07       Impact factor: 1.780

4.  Radioembolisation using yttrium 90 (Y-90) in patients affected by unresectable hepatic metastases.

Authors:  R Cianni; C Urigo; E Notarianni; A Saltarelli; A D'Agostini; M Iozzino; T Dornbusch; E Cortesi
Journal:  Radiol Med       Date:  2010-01-20       Impact factor: 3.469

5.  Role of yttrium-90 in the management of unresectable hepatocellular carcinoma and hepatic metastases.

Authors:  Vankadari Kousik; Pankaj Promila; Ritu Verma; Arun Gupta
Journal:  Indian J Gastroenterol       Date:  2016-05-16

Review 6.  Studies on the treatment and prevention of colorectal liver metastases.

Authors:  I Taylor
Journal:  Ann R Coll Surg Engl       Date:  1981-07       Impact factor: 1.891

7.  Treatment of hepatocellular carcinoma by transcatheter hepatic arterial injection of radioactive iodized oil solution.

Authors:  Y Yumoto; K Jinno; S Inatsuki; S Moriwaki; T Hanafusa; E Yumoto; T Shiota; T Higashi; N Koide; H Hada
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

8.  Trans-arterial hepatic radioembolisation of yttrium-90 microspheres.

Authors:  R Murthy; A Habbu; R Salem
Journal:  Biomed Imaging Interv J       Date:  2006-07-01

9.  Relationship of 99mtechnetium labelled macroaggregated albumin (99mTc-MAA) uptake by colorectal liver metastases to response following Selective Internal Radiation Therapy (SIRT).

Authors:  Atul Dhabuwala; Prue Lamerton; Richard S Stubbs
Journal:  BMC Nucl Med       Date:  2005-12-23

10.  Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study.

Authors:  W Y Lau; W T Leung; S Ho; N W Leung; M Chan; J Lin; C Metreweli; P Johnson; A K Li
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.